Myofilament proteins: From cardiac disorders to proteomic changes

Proteomics - Clinical Applications

Volumn 2, Issue 6, 2008, Pages 788-799

  Yuan, Chao ^a   Solaro, R John ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Heart; Oxidative stress; Phosphorylation; Protein isoforms; Sarcomere

Indexed keywords

ACTIN; CONTRACTILE PROTEIN; MYOSIN; TROPOMYOSIN; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; DOWNSTREAM PROCESSING; HEART CONTRACTION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART OUTPUT; HUMAN; MOLECULAR MECHANICS; MYOFILAMENT; NITROSYLATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REGULATORY MECHANISM; REVIEW; SARCOMERE;

EID: 46749104084     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780076     Document Type: Review

References (125)

1. Solaro, R. J., Handbook of Physiology, Section 2: The Cardiovascular System, Vol I: The Heart. Oxford University Press, New York 2001.
2. Kobayashi, T., Solaro, R. J., Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu. Rev. Physiol. 2005, 67, 39-67.
3. 2+ with cardiac pump regulation and pump dynamics. Am. J. Physiol. 1999, 277, S155-163.
4. Solaro, R. J., Wolska, B. M., Arteaga, G., Martin, A. F. et al., in: Solaro, R. J., Moss, R. L., (Eds.), Molecular Control Mechanisms in Striated Muscle Contraction, The Netherlands 2002, pp, 291-327.
5. Hernandez, O. M., Jones, M., Guzman, G., Szczesna-Cordary, D., Myosin essential light chain in health and disease. Am. J. Physiol. Heart Circ. Physiol. 2007, 292, H1643-1654.
6. Moss, R. L., Fitzsimons, D. P., Myosin light chain 2 into the mainstream of cardiac development and contractility. Circ. Res. 2006, 99, 225-227.
7. Granzier, H. L., Campbell, K. B., New insights in the role of cardiac myosin binding protein C as a regulator of cardiac contractility. Circ. Res. 2006, 99, 795-797.
8. Granzier, H., Wu, Y., Siegfried, L., LeWinter, M., Titin: physiological function and role in cardiomyopathy and failure. Heart Fail. Rev. 2005, 10, 211-223.
9. Pi, Y., Kemnitz, K. R., Zhang, D., Kranias, E. G., Walker, J. W., Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Circ. Res. 2002, 90, 649-656.
10. Sumandea, M. P., Burkart, E. M., Kobayashi, T., De Tombe, P. P., Solaro, R. J., Molecular and integrated biology of thin filament protein phosphorylation in heart muscle. Ann. NY Acad. Sci. 2004, 1015, 39-52.
11. Vahebi, S., Kobayashi, T., Warren, C. M., de Tombe, P. P., Solaro, R. J., Functional effects of rho-kinase-dependent phosphorylation of specific sites on cardiac troponin. Circ. Res. 2005, 96, 740-747.
12. Vahebi, S., Ota, A., Li, M., Warren, C. M. et al., p38-MAPK induced dephosphorylation of alpha-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity. Circ. Res. 2007, 100, 408-415.
13. Deng, Y., Schmidtmann, A., Redlich, A., Westerdorf, B. et al., Effects of phosphorylation and mutation R145G on human cardiac troponin I function. Biochemistry 2001, 40, 14593-14602.
14. Lim, M. S., Sutherland, C., Walsh, M. P., Phosphorylation of bovine cardiac C-protein by protein kinase C. Biochem. Biophys. Res. Commun. 1985, 132, 1187-1195.
15. Hartzell, H. C., Effects of phosphorylated and unphosphorylated C-protein on cardiac actomyosin ATPase. J. Mol. Biol. 1985, 186, 185-195.
16. Stelzer, J. E., Patel, J. R., Walker, J. W., Moss, R. L., Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase a phosphorylation. Circ. Res. 2007, 101, 503-511.
17. Yuan, C., Ravi, R., Murphy, A. M., Discovery of disease-induced post-translational modifications in cardiac contractile proteins. Curr. Opin. Mol. Ther. 2005, 7, 234-239.
18. McGregor, E., Dunn, M. J., Proteomics of the heart: unraveling disease. Circ. Res. 2006, 98, 309-321.
19. Stanley, B. A., Gundry, R. L., Cotter, R. J., Van Eyk, J. E., Heart disease, clinical proteomics and mass spectrometry. Dis. Markers 2004, 20, 167-178.
20. Scruggs, S. B., Walker, L. A., Lyu, T., Geenen, D. L. et al., Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation. J. Mol. Cell. Cardiol. 2006, 40, 465-473.
21. Granzier, H. L., Wang, K., Gel electrophoresis of giant proteins: solubilization and silver-staining of titin and nebulin from single muscle fiber segments. Electrophoresis 1993, 14, 56-64.
22. Yuan, C., Guo, Y., Ravi, R., Przyklenk, K. et al., Myosin binding protein C is differentially phosphorylated upon myocardial stunning in canine and rat hearts- evidence for novel phosphorylation sites. Proteomics 2006, 6, 4176-4186.
23. Arrell, D. K., Neverova, I., Fraser, H., Marban, E., Van Eyk, J. E., Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ. Res. 2001, 89, 480-487.
24. McDonough, J. L., Neverova, I., Van Eyk, J. E., Proteomic analysis of human biopsy samples by single two-dimensional electrophoresis: Coomassie, silver, mass spectrometry, and Western blotting. Proteomics 2002, 2, 978-987.
25. Kane, L. A., Neverova, I., Van Eyk, J. E., Subfractionation of heart tissue: the "in sequence" myofilament protein extraction of myocardial tissue. Methods Mol. Biol. 2007, 357, 87-90.
26. Holroyde, M. J., Small, D. A., Howe, E., Solaro, R. J., Isolation of cardiac myofibrils and myosin light chains with in vivo levels of light chain phosphorylation. Biochim. Biophys. Acta 1979, 587, 628-637.
27. Pan, B. S., Solaro, R. J., Calcium-binding properties of troponin C in detergent-skinned heart muscle fibers. J. Biol. Chem. 1987, 262, 7839-7849.
28. Layland, J., Cave, A. C., Warren, C., Grieve, D. J. et al., Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. FASEB J. 2005, 19, 1137-1139.
29. Miegel, A., Kobayashi, T., Maeda, Y., Isolation, purification and partial characterization of tropomyosin and troponin subunits from the lobster tail muscle. J. Muscle Res. Cell. Motil. 1992, 13, 608-618.
30. Tobacman, L. S., Lee, R., Isolation and functional comparison of bovine cardiac troponin T isoforms. J. Biol. Chem. 1987, 262, 4059-4064.
31. Gao, W. D., Atar, D., Liu, Y., Perez, N. G. et al., Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ. Res. 1997, 80, 393-399.
32. Van Eyk, J. E., Powers, F., Law, W., Larue, C. et al., Breakdown and release of myofilament proteins during ischemia and ischemia/ reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ. Res. 1998, 82, 261-271.
33. McDonough, J. L., Arrell, D. K., Van Eyk, J. E., Troponin I degradation and covalent complex formation accompanies myocardial ischemia/ reperfusion injury. Circ. Res. 1999, 84, 9-20.
34. Yu, Z. B., Zhang, L. F., Jin, J. P., A proteolytic NH2-terminal truncation of cardiac troponin I that is up-regulated in simulated microgravity. J. Biol. Chem. 2001, 276, 15753-15760.
35. Labugger, R., Organ, L., Collier, C., Atar, D., Van Eyk, J. E., Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 2000, 102, 1221-1226.
36. Morjana, N. A., Degradation of human cardiac troponin I after myocardial infarction. Biotechnol. Appl. Biochem. 1998, 28, 105-111.
37. Madsen, L. H., Christensen, G., Lund, T., Serebruany, V. L. et al., Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy. Circ. Res. 2006, 99, 1141-1147.
38. Zeitz, O., Maass, A. E., Van Nguyen, P. et al., Hydroxyl radical-induced acute diastolic dysfunction is due to calcium overload via reverse-mode Na(+)-Ca(2+) exchange. Circ. Res. 2002, 90, 988-995.
39. Fishbein, M. C., Wang, T., Matijasevic, M., Hong, L., Apple. F. S., Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia. Cardiovasc. Pathol. 2003, 12, 65-71.
40. Wu, A. H., Feng, Y. J., Moore, R., Apple, F. S. et al., Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnl Standardization. Clin. Chem. 1998, 44, 1198-1208.
41. Michielsen, E. C., Diris, J. H., Kleijnen, V. W., Wodzig, W. K., Van Dieijen-Visser, M. P., Investigation of release and degradation of cardiac troponin T in patients with acute myocardial infarction. Clin. Biochem. 2007, 40, 851-855.
42. Alpert, J. S., Thygesen, K., Antman, E., Bassand, J. P., Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 2000, 36, 959-969.
43. Altinier, S., Mion, M., Cappelletti, A., Zaninotto, M., Plebani, M., Rapid measurement of cardiac markers on Stratus CS. Clin. Chem. 2000, 46, 991-993.
44. Hickman, P. E., Koerbin, G., Southcott, E., Tate, J. R. et al., Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease. Ann. Clin. Biochem. 2007, 44, 285-289.
45. Saadeddin, S. M., Habbab, M. A., Siddieg, H. H., Al Seeni, M. N. et al., Evaluation of 6 cardiac troponin assays in patients with acute coronary syndrome. Saudi Med. J. 2003, 24, 1092-1097.
46. White, M. Y., Cordwell, S. J., McCarron, H. C., Prasan, A. M. et al., Proteomics of ischemia/reperfusion injury in rabbit myocardium reveals alterations to proteins of essential functional systems. Proteomics 2005, 5, 1395-1410.
47. Decker, R. S., Decker, M. L., Kulikovskaya, I., Nakamura, S. et al., Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia. Circulation 2005, 111, 906-912.
48. Zolk, O., Schenke, C., Sarikas, A., The ubiquitin-proteasome system: focus on the heart. Cardiovasc. Res. 2006, 70, 410-421.
49. Willis, M. S., Patterson, C., Into the heart: the emerging role of the ubiquitin-proteasome system. J. Mol. Cell. Cardiol. 2006, 41, 567-579.
50. Weekes, J., Wheeler, C. H., Yan, J. X., Weil, J. et al., Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis 1999, 20, 898-906.
51. Weekes, J., Morrison, K., Mullen, A., Wait, R. et al., Hyper-ubiquitination of proteins in dilated cardiomyopathy. Proteomics 2003, 3, 208-216.
52. Solomon, V., Goldberg, A. L., Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J. Biol. Chem. 1996, 271, 26690-26697.
53. Williams, A. B., Decourten-Myers, G. M., Fischer, J. E., Luo, G. et al., Sepsis stimulates release of myofilaments in skeletal muscle by a calcium-dependent mechanism. FASEB J. 1999, 13, 1435-1343.
54. Goll, D. E., Thompson, V. F., Li H, Wei, W., Cong, J., The calpain system. Physiol. Rev. 2003, 83, 731-801.
55. Marban, E., Kitakaze, M., Koretsune, Y., Yue, D. T. et al., Quantification of [Ca2+]i in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circ. Res. 1990, 66, 1255-1267.
56. 2 activation of HSP25/27 protects desmin from calpain proteolysis in rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H1518-H1525.
57. Barta, J., Toth, A., Edes, I., Vaszily, M. et al., Calpain-1-sensitive myofibrillar proteins of the human myocardium. Mol. Cell. Biochem. 2005, 278, 1-8.
58. Maekawa, A., Lee, J. K., Nagaya, T., Kamiya, K. et al., Overexpression of calpastatin by gene transfer prevents troponin I degradation and ameliorates contractile dysfunction in rat hearts subjected to ischemia/reperfusion. J. Mol. Cell. Cardiol. 2003, 35, 1277-1284.
59. Kane, L. A., Yung, C. K., Agnetti, G., Neverova, I., Van Eyk. J. E., Optimization of paper bridge loading for 2-DE analysis in the basic pH region: application to the mitochondrial subproteome. Proteomics 2006, 6, 5683-5687.
60. Unlu, M., Morgan, M. E., Minden, J. S., Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
61. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R. et al., Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001, 1, 377-396.
62. Filatov, V. L., Katrukha, A. G., Bereznikova, A. V., Esakova, T. V. et al., Epitope mapping of anti-troponin I monoclonal antibodies. Biochem. Mol. Biol. Int. 1998, 45, 1179-1187.
63. Murphy, A. M., Kogler, H., Georgakopoulos, D., McDonogh, J. L. et al., Transgenic mouse model of stunned myocardium. Science 2000, 287, 488-491.
64. Marston, S. B., Redwood, C. S., Modulation of thin filament activation by breakdown or isoform switching of thin filament proteins: physiological and pathological implications. Circ. Res. 2003, 93, 1170-1178.
65. Anderson, P. A., in: Solaro, R. J., Moss, R. L. (Eds.), Molecular Control Mechanisms in Striated Muscle Contraction. Kluwer Academic Publishers, The Netherlands, 2002, pp 329-377.
66. VanBuren, P., Okada, Y., Thin filament remodeling in failing myocardium. Heart Fail. Rev. 2005, 10, 199-209.
67. Ritter, O., Luther, H. P., Haase, H., Baltas, L. G. et al., Expression of atrial myosin light chains but not alpha-myosin heavy chains is correlated in vivo with increased ventricular function in patients with hypertrophic obstructive cardiomyopathy. J. Mol. Med. 1999, 77, 677-685.
68. Reiser, P. J., Portman, M. A., Ning, X. H., Schomisch Moravec, C., Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am. J. Physiol. Heart Circ. Physiol. 2001, 280, H1814-1820.
69. Thijssen, V. L., Ausma, J., Gorza, L., van der Velden, H. M. et al., Troponin I isoform expression in human and experimental atrial fibrillation. Circulation 2004, 110, 770-775.
70. Warren, C. M., Jordan, M. C, Roos, K. P., Krzesinski, P. R., Greaser, M. L., Titin isoform expression in normal and hypertensive myocardium. Cardiovasc. Res. 2003, 59, 86-94.
71. Goldspink, G., Gene expression in muscle in response to exercise. J. Muscle Res. Cell. Motil. 2003, 24, 121-126.
72. Schiaffino, S., Reggiani, C., Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol. Rev. 1996, 76, 371-423.
73. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
74. Bodor, G. S., Oakeley, A. E., Allen, P. D., Crimmins, D. L. et al., Troponin I phosphorylation in the normal and failing adult human heart. Circulation 1997, 96, 1495-1500.
75. Reiser, P. J., Kline, W. O., Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species. Am. J. Physiol. 1998, 274, H1048-1053.
76. Biesiadecki, B. J., Elder, B. D., Yu, Z. B., Jin, J. P., Cardiac troponin T variants produced by aberrant splicing of multiple exons in animals with high instances of dilated cardiomyopathy. J. Biol. Chem. 2002, 277, 50275-50285.
77. Warren, C. M., Krzesinski, P. R., Greaser, M. L., Vertical agarose gel electrophoresis and electroblotting of high-molecular-weight proteins. Electrophoresis 2003, 24, 1695-1702.
78. 2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc. Res. 2003, 57, 37-47.
79. Gautel, M., Leonard, K., Labeit, S., Phosphorylation of KSP motifs in the C-terminal region of titin in differentiating myoblasts. EMBO J. 1993, 12, 3827-3834.
80. Mohamed, A. S., Dignam, J. D., Schlender, K. K., Cardiac myosin-binding protein C (MyBP-C): identification of protein kinase A and protein kinase C phosphorylation sites. Arch. Biochem. Biophys. 1998, 358, 313-319.
81. Geisler, N., Weber, K., Phosphorylation of desmin in vitro inhibits formation of intermediate filaments; identification of three kinase A sites in the aminoterminal head domain. EMBO J. 1988, 7, 15-20.
82. Jideama, N. M., Noland, T. A., Jr., Raynor, R. L. Blobe, G. C. et al., Phosphorylation specificities of protein kinase C isozymes for bovine cardiac troponin I and troponin T and sites within these proteins and regulation of myofilament properties. J. Biol. Chem. 1996, 271, 23277-23283.
83. Noland, T. A., Jr., Raynor, R. L., Kuo, J. F., Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites. J. Biol. Chem. 1989, 264, 20778-20785.
84. Ikebe, M., Hartshorne, D. J., Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J. Biol. Chem. 1985, 260, 10027-10031.
85. Layland, J., Solaro, R. J., Shah, A. M., Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc. Res. 2005, 66, 12-21.
86. Sadayappan, S., Gulick, J., Osinska, H., Martin, L. A. et al., Cardiac myosin-binding protein-C phosphorylation and cardiac function. Circ. Res. 2005, 97, 1156-1163.
87. Kobayashi, T., Yang, X., Walker, L. A., Van Breemen, R. B., Solaro, R. J., A non-equilibrium isoelectric focusing method to determine states of phosphorylation of cardiac troponin I: identification of Ser-23 and Ser-24 as significant sites of phosphorylation by protein kinase C. J. Mol. Cell. Cardiol. 2005, 38, 213-218.
88. Zhan, X., Desiderio, D. M., The human pituitary nitroproteome: detection of nitrotyrosyl-proteins with two-dimensional Western blotting, and amino acid sequence determination with mass spectrometry. Biochem. Biophys. Res. Commun. 2004, 325, 1180-1186.
89. White, M. Y., Cordwell, S. J., McCarron, H. C., Tchen, A. S. et al., Modifications of myosin-regulatory light chain correlate with function of stunned myocardium. J. Mol. Cell. Cardiol. 2003, 35, 833-840.
90. 2+ by phosphorylating troponin I on threonine-144. J. Mol. Cell. Cardiol. 2006, 41, 823-833.
91. Karczewski, P., Bartel, S., Krause, E. G., Differential sensitivity to isoprenaline of troponin I and phospholamban phosphorylation in isolated rat hearts. Biochem. J. 1990, 266, 115-122.
92. Goldspink, P. H., Montgomery, D. E., Walker, L. A., Urboniene, D. et al., Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ. Res. 2004, 95, 424-432.
93. Messer, A. E., Jacques, A. M., Marston, S. B., Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J. Mol. Cell. Cardiol. 2007, 42, 247-259.
94. Wu, S. C., Solaro, R. J., Protein kinase c zeta: A novel regulator of both phosphorylation and de-phosphorylation of cardiac sarcomeric proteins. J. Biol. Chem. 2007.
95. Xiao, L., Zhao, Q., Du, Y., Yuan, C. et al., PKCepsilon increases phosphorylation of the cardiac myosin binding protein C at serine 302 both in vitro and in vivo. Biochemistry 2007, 46, 7054-7061.
96. MacCoss, M. J., McDonald, W. H., Saraf, A., Sadygov, R. et al., Shotgun identification of protein modifications from protein complexes and lens tissue. Proc. Natl. Acad. Sci. USA 2002, 99, 7900-7905.
97. Kange, R., Selditz, U., Granberg, M., Lindberg, V. et al., Comparison of different IMAC techniques used for enrichment of phosphorylated peptides. J. Biomol. Tech. 2005, 16, 91-103.
98. Yang, X., Wu, H., Kobayashi, T., Solaro, R. J., van Breemen, R. B., Enhanced ionization of phosphorylated peptides during MALDI TOF mass spectrometry. Anal. Chem. 2004, 76, 1532-1536.
99. Ficarro, S. B., McCleland, M. L., Stukenberg, P. T., Burke, D. J. et al., Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 2002, 20, 301-305.
100. Larsen, M. R., Thingholm, T. E., Jensen, O. N., Roepstorff, P., Jorgensen, T. J., Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell. Proteomics 2005, 4, 873-86.
101. Kweon, H. K., Hakansson, K., Selective zirconium dioxide-based enrichment of phosphorylated peptides for mass spectrometric analysis. Anal. Chem. 2006, 78, 1743-1749.
102. Cooper, H. J., Hakansson, K., Marshall, A. G., The role of electron capture dissociation in biomolecular analysis. Mass Spectrom. Rev. 2005, 24, 201-222.
103. Mikesh, L. M., Ueberheide, B., Chi, A., Coon, J. J. et al., The utility of ETD mass spectrometry in proteomic analysis. Biochim. Biophys. Acta 2006, 1764, 1811-1822.
104. Yuan, C., Solaro, R. J., Quantitative comparison of myofilament phospho-proteomes of neonatal and adult rat hearts. In: ASMS, Indianoplis, IN 2007.
105. Seddon, M., Looi, Y. H., Shah, A. M., Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2007, 93, 903-907.
106. Takimoto, E., Kass, D. A., Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 2007, 49, 241-248.
107. Ungvari, Z., Gupte, S. A., Recchia, F. A., Batkai, S., Pacher, P., Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr. Vasc. Pharmacol. 2005, 3, 221-229.
108. Prasan, A M., McCarron, H. C., Zhang, Y., Jeremy, R. W., Myocardial release of nitric oxide during ischaemia and reperfusion: Effects of l-arginine and hypercholesterolaemia. Heart Lung Circ. 2007, 16, 274-281.
109. Duncan, J. G., Ravi, R., Stull, L. B., Murphy, A. M., Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2005, 289, H1512-1518.
110. Mihm, M. J., Yu, F., Weinstein, D. M., Reiser, P. J., Bauer, J. A., Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase. Br. J. Pharmacol. 2002, 135, 581-588.
111. Dai, T., Tian, Y., Tocchetti, C. G., Katori, T. et al., Nitroxyl increases force development in rat cardiac muscle. J. Physiol. 2007, 580, 951-960.
112. Shacter, E., Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev. 2000, 32, 307-326.
113. Canton, M., Neverova, I., Menabo, R., Van Eyk, J., Di Lisa, F., Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H870-877.
114. Kanski, J., Behring, A., Pelling, J., Schoneich, C., Proteomic identification of 3-nitrotyrosine-containing rat cardiac proteins: effects of biological aging. Am. J. Physiol. Heart Circ. Physiol. 2005, 288, H371-381.
115. Kanski, J., Alterman, M.A., Schoneich, C., Proteomic identification of age-dependent protein nitration in rat skeletal muscle. Free Radic. Biol. Med. 2003, 35, 1229-1239.
116. Kanski, J., Hong, S. J., Schoneich, C., Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine-containing sequences in vivo by nano-electrospray ionization tandem mass spectrometry. J. Biol. Chem. 2005, 280, 24261-24266.
117. Hong, S. J., Gokulrangan, G., Schoneich, C., Proteomic analysis of age dependent nitration of rat cardiac proteins by solution isoelectric focusing coupled to nanoHPLC tandem mass spectrometry. Exp. Gerontol. 2007, 42, 639-651.
118. Sethuraman, M., McComb, M. E., Huang, H., Huang, S. et al., Isotope-coded affinity tag (ICAT) approach to redox proteomics: identification and quantitation of oxidant-sensitive cysteine thiols in complex protein mixtures. J. Proteome Res. 2004, 3, 1228-1233.
119. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F. et al., Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
120. Dalle-Donne, S., Scaloni, A., Butterfield, D. A., Redox Proteomics: From Protein Modifications to Cellular Dysfunction and Diseases. John Wiley & Sons, Hoboken, NJ 2006.
121. Kislinger, T., Gramolini, A. O., MacLennan, D. H., Emili, A., Multidimensional protein identification technology (Mud-PIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. J. Am. Soc. Mass Spectrom. 2005, 16, 1207-1220.
122. Ge, Y., Walker, J. W., Gumerov, D. R., Easterling, M. L., Speir, J. P., Localization of phosphorylation sites in human cardiac troponin I by top down electron capture dissociation mass spectrometry In: HUPO 5th World Congress. Long Beach, CA 2006.
123. Verduyn, S. C., Zaremba, R., van der Velden, J., Stienen, G. J., Effects of contractile protein phosphorylation on force development in permeabilized rat cardiac myocytes. Basic Res. Cardiol. 2007, 102, 476-487.
124. Di Lisa, F., De Tullio, R., Salamino, F., Barbato, R. et al., Specific degradation of troponin T and I by mu-calpain and its modulation by substrate phosphorylation. Biochem. J. 1995, 308, 57-61.
125. Zhang, Z., Biesiadecki, B. J., Jin, J. P., Selective deletion of the NH2-terminal variable region of cardiac troponin T in ischemia reperfusion by myofibril-associated mu-calpain cleavage. Biochemistry 2006, 45, 11681-11694.